Provides More Than Six Million US Lives Unrestricted Access to Only FDA-Approved 12-Hour Codeine-Based Cold-Cough Syrup ENGLEWOOD, CO / ACCESSWIRE...
KING OF PRUSSIA, PA / ACCESSWIRE / November 19, 2019 / Chronic Kidney Disease (CKD) is a world-wide affliction. Many...
Experienced executive will accelerate company’s growth in quickly developing market SALT LAKE CITY--(BUSINESS WIRE)--Clinical Innovations, one of the world’s largest...
NANAIMO, BC / ACCESSWIRE / November 18, 2019 / The Denturist Association of BC (DABC) is demanding that the government...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--InterVenn Biosciences, a company in the life sciences and technology sector, is pleased to announce that the...
NEW YORK, NY / ACCESSWIRE / November 18, 2019 / Kadmon Holdings, Inc. (NYSE:KDMN) today announced the closing of its...
TORONTO, ON / ACCESSWIRE / November 18, 2019 / Intellipharmaceutics International Inc. (OTCQB:IPCIF and TSX:IPCI) ("Intellipharmaceutics" or the "Company") and...
HERZELIYA, ISRAEL and CALGARY, ALBERTA / ACCESSWIRE / November 18, 2019 / InnoCan Pharma Corporation ("InnoCan" or the "Company") (CSE:INNO)...
MINNEAPOLIS--(BUSINESS WIRE)--#Healthcare--In a move that reflects Medical Alley’s position as the global epicenter of health innovation and care, the Medical...
Collective partners with Kno2 to enable physician and care team members with high-value clinical insights at the point of care...
BAD HOMBURG, GERMANY – The first patients are about to be enrolled in the EuroPN survey, a clinical study that...
LOS ANGELES, CA / ACCESSWIRE / November 18, 2019 / International Cannabrands Inc. (CSE:INCB) (the "Company") is pleased to announce...
The fear that dental professionals may be replaced by robots is as real as the excitement of wondering what the...
Operational Update LONDON, UK / ACCESSWIRE / November 18, 2019 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new...
— Study results reflect advancements in HER2-positive, triple-negative, and hormone receptor-positive breast cancer — — Follow-up data from pivotal Phase...
PLANEGG/MUNICH, GERMANY and BOSTON MA / ACCESSWIRE / November 15, 2019 / MorphoSys (FSE: MOR; Prime Standard Segment; MDAX & TecDAX;...
Organizational decision-makers continue to make remarkable progress in leveraging technology to improve operations as well as patient treatment outcomes. Long...
This press release replaces the press release issued 11/15/2019 at 6:30 a.m., which included an incorrect date. The company had...
BURLINGAME, CA / ACCESSWIRE / November 15, 2019 / Humanigen, Inc., (OTCQB:HGEN) ("Humanigen"), a clinical stage biopharmaceutical company focused on...
Successfully building BioPharma pipeline in high-value indications Company plans to advance IND-cleared program into a Phase 1 study in a...